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impact on biology. To be fair, these research areas are transcription complexes, although well developed, could
be further supported by discussing in more detail thestill in their infancy and will have to mature considerably
work on the enhanceosome, as revealed by studies onbefore their informatics textbooks can be written.
the transcriptional regulation of interferon-b expression.
Nonetheless, this chapter, the last in the ªTranscriptionalOxana K. Pickeral* and Mark S. Boguski²
Regulationº section, represents as complete and schol-*Department of Molecular Biology and Genetics
arly a review at a general level as currently exists.The Johns Hopkins University School of Medicine
The book's second section, ªTranscriptional Patho-Baltimore, Maryland 21205
physiology,º commences with a review of mutations in²Computational Biology Branch
cis-acting transcriptional regulatory elements. Some ofNational Center for Biotechnology Information
this material is old hat: promoter mutations in theNational Library of Medicine
b-globin promoter in thalassemia, or in the F9 promoterNational Institutes of Health
encoding Factor IX in hemophilia B Leyden. But it canBethesda, Maryland 20894
be fairly argued that information of this sort belongs in
this text. A fascinating example is the acquisition of
promoter mutations in the DARC gene that encodes the
Duffy antigen that also serves as a receptor for the
Humans as Model Organisms malarial parasite Plasmodium vivax. These mutations
are prevalent at high frequency in West Africa where
malaria is endemic, providing an example whereby mu-Transcription Factors and Human Disease
tations influencing transcription also serve as diseaseOxford Monographs on Medical Genetics, No. 37
modifiers. Other examples remain unproven, such asBy Gregg L. Semenza
the notion that the trinucleotide repeat expansion in theOxford: Oxford University Press. (1998). 368 pp. $49.95
Fragile X syndrome gene FMR1 interferes with a cis-
acting regulatory element. However, their inclusion does
serve to illustrate the diversity of mechanisms by whichSince the golden age of phage and bacterial genetics,
the transcriptional control of gene expression can bethe power of genetic mutants to elucidate basic bio-
disrupted to produce a phenotype.chemical and developmental pathways has been self-
The most useful chapters of the book are those thatevident. In the time since, countless mutations, ranging
follow, organized by transcription factor family, e.g., nu-from behavioral to developmental to physiologic have
clear receptors, other Zn finger proteins, Pax, bHLH,been identified in organisms as diverse as yeast, worms,
homeodomain, HMG, and POU proteins. These chaptersflies, and fish. This trend has been further facilitated by
deal with transcription factor families in the context ofthe current ascendancy of mouse molecular genetics.
some 40 different human mutational syndromes. TheYet the argument can be made that, among all organ-
information on syndromes such as Rieger, Denys-Drash,isms, the human remains the species in which the most
Waardenburg (type 1±3), Aniridia, and Hand±Foot Geni-sophisticated armamentarium of analytical and pheno-
tal, representing mutations in PITX1, WT1, PAX3 and
typic analyses can be brought to bear. In addition, a
MITF, PAX6 and HOXA13, respectively, is well presented
pragmatic aspect to the analysis of human mutant phe-
and concise and accurately summarizes the present
notypes is their relevance to human disease. It is per- level of understanding about the individual gene prod-
haps with these premises in mind that Transcription ucts and about phenotype±genotype correlations. A
Factors and Human Disease, by G. L. Semenza, has particularly nice feature of this portion of the book is the
been prepared. integration of instructive results from other organisms,
The text is divided into two sections, entitled ªTran- mice in particular. Another attractive feature is the
scriptional Regulationº and ªTranscriptional Pathophys- numbers accompanying each syndrome that facilitate
iology.º The first presents a survey of gene expression, cross-reference to Online Mendelian Inheritance in Man
transcriptional regulation, and cis-acting transcriptional (OMIM; http://www.nih.gov/omim). Students of human
regulatory elements. Chapters 1 and 2, dealing with tran- biology will thus find this material accessible, useful,
scription initiation, promoter structure, enhancers, chro- and remarkably thoroughÐalthough inevitably outdated.
matin looping, and negative regulatory elements, are Given the current pace at which human disease±pro-
rather perfunctory. However, following this introductory ducing mutations are being identified and the fact that
material is a remarkably detailed chapter on trans-acting subsequent editions of other volumes in the Oxford
factors, subdivided into discussions of activators, co- Monographs series have appeared, future editions of
activators, architectural factors, repressors and core- this work would seem to be in order.
pressors, chromatin remodeling, and transcription elon- As with any well-prepared treatise, this work raises
gation factors. Some of the material, for example, the as many interesting questions as it answers. Why, for
discussion of TAFs, suffers from the complex and yet example, should mutations involving genes that function
incompletely understood relationships between these widely in transcriptional regulationÐsuch as XH2 and
different factors. And, although the situation will proba- CBPÐresult in highly specific developmental defects?
bly change, among the components of the basal tran- Mutations in XH2, a widely expressed helicase thought
scription apparatus, only mutations in one of them, XPB/ to regulate transcription globally, result in the ATR-X
ERCC3, a subunit of TFIIH, have been associated with syndrome, defined by X-linked a-thalassemia, facial and
human disease (Xeroderma pigmentosum B and Cock- genital abnormalities, and mental retardation. The co-
activator CBP participates in a plethora of importantayne syndrome). In addition, the work on multiprotein
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transcriptional events, including not only its named fact, a survey of OMIM reveals that of the human genetic
function as a coactivator for the phosphorylated form diseases for which genes are identified, only a small
of CREB (cAMP response element±binding protein), but minority are caused by mutations in genes encoding
also the regulation of histone acetylation. Yet while inhi- transcription factors. While the restricted focus of this
bition of expression of a C. elegans CBP homolog results work on transcription factors is pragmatic, it is also thus
in a complete absence of somatic morphogenesis, intra- somewhat contrived. For example, the text describes
genic mutations in human CBP are associated with a the involvement of the MSX2 homeobox gene in Boston-
comparatively restricted phenotype, Rubinstein-Taybi type craniosynostosis, a disorder characterized by pre-
syndrome, a dysmorphosis characterized by specific mature fusion of the sutures of the newborn skull. The
limb and craniofacial defects and mental retardation. more frequent and better-characterized craniosynos-
Since these genes are members of multigene familiesÐ tosis syndromes, however, are due to mutations in three
CBP shares homology with another coactivator, P300, of the FGF receptor genes. Left unexplored is what rela-
while XH2 is a member of the helicase superfamilyÐtheir tion, if any, exists between FGF signaling and MSX2 in
restricted mutant phenotypes might be explained on the sutural biology. Ideally, the molecular function of tran-
basis of functional redundancy. What seems equally scription factors is best understood in the context of
likely, howeverÐif unpleasantly more complexÐis that their biologic function, and vice versa.
it is the function of the gene product in the context of Currently, the number of human genetic diseases
the specific biology of the organism that dictates listed in OMIM exceeds 10,000. As more and more dis-
whether and what identifiable phenotype will result. ease-producing genes are identified, an attractive pros-
Interestingly, Rubinstein-Taybi syndrome has been pect for the future is their integrationÐwhether they
associated at low frequency with a variety of other con- encode transcription factors or notÐinto specific path-
genital malformations, raising the possibility that the ways based on the analysis of their respective mutant
phenotypic expression of this disease results from poly- phenotypes. Of course, studies in humans are necessar-
morphic differences in the expression levels of other ily limited in their potential for embryologic and genetic
genes whose products interact with CBP. In the future, investigation, but they do provide a powerful starting
it can be anticipated that the identification of disease point. Although this book is useful, left unconnected for
producing genes that must interact in specific allelic the moment is the link between its first and second
combinations to produce morbid phenotypes will further sections, between molecular function and an under-
underscore the utility of the human as a model organism standing of organismal function. At present, these sec-
for understanding complex polygenic traits, such as in- tions can only cross-refer to one another. One can imag-
telligence, blood pressure, and disease susceptibility. ine, however, that future editions will begin to bridge
What are the practical consequences of the continued this gap.
delineation of human transcription factor diseases? A
potential answer is provided in the book's last chapter,
Richard Maas
entitled ªEpigenetic Mechanisms.º This chapter deals
Genetics Divisionwith the well-known propensity of teratogens such as
Department of Medicineretinoic acid and ethanol to induce congenital birth de-
Brigham and Women's Hospital andfects that phenotypically resemble those observed in
Harvard Medical Schoolsome transcription factor diseases. Although their ter-
Boston, Massachusetts 02115atogenic mechanisms are poorly understood, the idea
that epigenetic factors converge on basic transcriptional
regulatory pathways during fetal development is highly
attractive. Studies have shown, for example, that prena-
tal folate significantly reduces the incidence of neural DNA Repair in the 1990s
tube defects such as spina bifida and anencephaly; as
a result, the U.S. Food and Drug Administration now
DNA Damage and Repairrequires fortification of enriched grain foods with folic
Volume 1: DNA Repair in Prokaryotes and Lower Eu-acid. Provocatively, a mouse mutant deficient for the
karyoteshomeodomain transcription factor Cart1 exhibits anen-
Volume 2: DNA Repair in Higher Eukaryotescephaly, and the incidence of this neural tube defect
Edited by Jac A. Nickoloff and Merl F. Hoekstrais also strongly suppressed by prenatal folate. Thus,
Totowa, NJ: Humana Press (1998). Vol. 1, 626 pp.knowledge of the transcriptional regulatory pathways
$125.00; Vol. 2, 639 pp. $125.00that govern human development may someday make it
possible to understand how factors such as folate work,
A Dallas Cowboys linebacker intercepted a pass as aand to devise new strategies for the prevention of birth
rookie and he made his second interception a decadedefects.
later. When he was asked to comment about this longAnother question, encouraged by the book's title, is
hiatus between the two interceptions he is reported towhether mutations in genes encoding transcription fac-
have said that everyone was entitled to an off decade.tors are any more likely to cause developmental malfor-
It appears that the field of DNA repair followed themation syndromes than genes encoding other factors.
same philosophy. After several momentous discoveries,In the preface, the author implies that this might be
which laid the foundation of the discipline in the 1960s,so, since transcription factors in general are thought to
the repair community had an off decade lasting fromregulate the expression of multiple downstream genes.
about 1968 until 1977. In the 1960s the first known repairYet the same argument can be made about the signal
transduction pathways that growth factors activate. In pathways were characterized, and it was shown that
